CORIFACT 250
CORIFACT 250
Approved
DIN Number
02418738
Drug Class
Human
Market Date
Apr 3, 2014
Company
HC
csl behring canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02418738
AIG Number0155190001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD07 COAGULATION FACTOR XIII
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
FACTOR XIIIActive
Strength: 250 UNIT / VIAL
Monograph: FACTOR XIII